If you strip investing down to its bare, unfriendly bones, you end up with a simple reality: over long periods, your returns converge toward the quality of the people running your money and the businesses you own. Balance sheets matter, valuations matter, industry...
founder-led investing
Growing Like A Weed: A Strategic Play in Pharmaceutical Manufacturing
In the rapidly evolving world of medical cannabis, one Australian company is quietly positioning itself as a potential industry leader. Bioxyne (BXN.ASX), a relatively young public company, is rewriting the playbook for medical cannabis manufacturing through a...


